Treatment as Prevention
Treatment as Prevention
IAS 2011: The Proof is Here: HIV Treatment is HIV Prevention
- Details
- Category: Treatment as Prevention
- Published on Tuesday, 19 July 2011 00:00
- Written by Paul Dalton
Antiretroviral treatment was shown to prevent HIV infection in the large, randomized trial HPTN 052 trial, reducing risk by 96%, researchers reported at IAS 2011 this week in Rome.
"There is a clinical benefit for the patient and a dramatic, nearly 100% reduction in transmission," said lead investigator Myron Cohen. "We can't get much better." 
IAS 2011: HIV Treatment as Prevention: HPTN 052 Offers Proof [VIDEO]
- Details
- Category: Treatment as Prevention
- Published on Tuesday, 19 July 2011 00:00
- Written by Gregory Fowler
HPTN 052 lead investigator Myron Cohen talked to Paul Dalton from HIVandHepatitis.com about the study's findings and their significance. 
IAS 2011: AIDS is at a Scientific Watershed [VIDEO]
- Details
- Category: Pre-exposure Prophylaxis (PrEP)
- Published on Sunday, 17 July 2011 00:00
- Written by Gregory Fowler
Speaking Sunday at the 6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011) opening plenary and press conference, IAS President and conference co-chair Elly Katabira underlined recent advances in biomedical prevention, including findings from the iPrEx, Partners PrEP and TDF2, and HPTN 052 trials showing that pre-exposure prophylaxis and early treatment can reduce HIV transmission. 
IAS 2011: Studies Confirm PrEP, Early ART Prevent HIV Transmission [VIDEO]
- Details
- Category: HIV Prevention
- Published on Monday, 18 July 2011 00:00
- Written by Liz Highleyman
Researchers at the 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011) taking place this week in Rome presented eagerly awaited data from 3 large trials showing that starting combination antiretroviral therapy (ART) early, and pre-exposure prophylaxis (PrEP) using tenofovir/emtricitabine, can dramatically cut the risk of HIV transmission.
Debate over Treatment for Prevention Continues
- Details
- Category: Treatment as Prevention
- Published on Friday, 15 July 2011 00:00
- Written by Matt Sharp
The ongoing debate about whether to start antiretroviral therapy with a CD4 cell count above 500 cells/mm3 for HIV positive people, as well as the widespread use of treatment for prevention in HIV negative people, has been inflamed by results from the HPTN 052 trial. 
Web Design and Development by